Add BrightSurf on Google Email

CHOP-led study finds daycare linked to increased complications in preterm children with chronic lung disease

A multicenter study found that preterm children with bronchopulmonary dysplasia who attend daycare are more likely to visit the emergency department, use systemic steroids, and experience chronic respiratory symptoms. The risk of these complications is highest in infants under 1 year old and may persist until 36 months of age.

SourceChildren's Hospital of Philadelphia·JournalThe Journal of Pediatrics·DateJul 26, 2022

A new treatment approach for cystic fibrosis

A new treatment approach using antisense oligonucleotides (ASOs) may help reduce cystic fibrosis symptoms and improve quality of life for patients with a specific gene mutation. The ASO strategy tricks cells into making an imperfect but functional version of the CFTR protein, which is better than having none at all.

SourceCold Spring Harbor Laboratory·JournalNature Communications·DateJul 14, 2022

Traditional Chinese medicine is effective for recurrent respiratory infections in children, says pediatric investigation study

A multicenter study found that traditional Chinese medicine Yupingfeng was as effective as allopathic drugs in treating recurrent respiratory tract infections in children. The study showed a substantially greater reduction in RRTI events and similar safety profiles across all three groups.

SourceCactus Communications·JournalPediatric Investigation·TypeRandomized controlled/clinical trial·DateJul 5, 2022

Black nursing home residents, those under age 65 more likely to have repeat transfers to hospital, MU study finds

A new study by University of Missouri found that Black nursing home residents and those under 65 are significantly more likely to experience repeat hospital transfers. This phenomenon can be attributed to various factors including 'full-code' status regarding end-of-life care, comorbidities, and inadequate staffing. The study suggests ...

SourceUniversity of Missouri-Columbia·JournalBMC Health Services Research·TypeMeta-analysis·DateJul 1, 2022

Pollution exposure associated with multimorbidity risk

A new study found that fine particulate matter (PM2.5) exposure is associated with an increased risk of having a cluster of multiple chronic diseases, particularly cardio-metabolic and respiratory conditions. The analysis revealed four distinct multimorbidity clusters, with lower PM2.5 exposure linked to musculoskeletal conditions.

SourcePLOS·JournalPLOS Global Public Health·TypeSurvey·DateJun 29, 2022

More than a quarter of people with asthma are still over-using rescue inhalers – putting them at increased risk of severe attacks and hospitalisation

A study by Queen Mary University of London found that 26% of patients with asthma are overusing rescue inhalers, which can lead to poor asthma control and increased risk of severe attacks. By reducing SABA overprescribing, hospitals can see a 70% decrease in asthma-related hospital admissions.

SourceQueen Mary University of London·JournalBritish Journal of General Practice·TypeData/statistical analysis·DateJun 15, 2022

Zinc found to play an important role in lung fibrosis

Researchers at Cedars-Sinai have discovered that zinc, a common mineral, plays an important role in reversing lung damage and improving survival for patients with idiopathic pulmonary fibrosis (IPF). By identifying a molecular pathway involving zinc, the team hopes to develop new therapies to reverse IPF-related lung damage.

SourceCedars-Sinai Medical Center·JournalJournal of Clinical Investigation·DateJun 8, 2022

Analysis finds additional clinical benefits of molnupiravir for nonhospitalized participants with COVID-19

A secondary analysis of the MOVe-OUT trial found molnupiravir-treated participants had a decreased need for respiratory interventions and fewer COVID-19-related acute care visits. Additionally, they showed faster normalization of biomarkers and were discharged earlier than placebo-treated patients.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeRandomized controlled/clinical trial·DateJun 6, 2022

Study reveals potential target for treatment of diseases associated with mitochondrial DNA mutations

A study by Brazilian scientists reveals that autophagy can modulate the accumulation of mutant mitochondrial DNA in cells during aging. The researchers found that mice with liver-specific atg7 knockout showed reduced buildup of mutant DNA, suggesting a potential therapeutic target for diseases associated with mitochondrial DNA mutations.

Breathing to win: Scientists show importance of screening breathing patterns in athletic populations

A recent study reveals that 91% of athletes display dysfunctional breathing patterns, which can lead to increased risk of musculoskeletal injuries. The study emphasizes the importance of screening and addressing these patterns through targeted interventions and breathing training protocols.

SourceRitsumeikan University·JournalThe Journal of Strength and Conditioning Research·TypeExperimental study·DateMay 26, 2022

Long COVID poses risks to vaccinated people, too

A new study found that vaccinated people with mild breakthrough COVID-19 infections can experience debilitating long COVID symptoms. Vaccination reduced the risk of death by 34% and long COVID by 15%, but not all manifestations were prevented. Researchers emphasize the need for additional layers of protection to mitigate risks.

SourceWashington University in St. Louis·JournalNature Medicine·TypeData/statistical analysis·DateMay 25, 2022

The gut microbiota compound that could become a drug for prevention and treatment of bronchiolitis

Researchers have discovered that short-chain fatty acid acetate from the gut microbiota can minimize the effects of infection by respiratory syncytial virus (RSV) and mitigate its severity. The compound was found to activate antiviral molecules, such as RIG-I, which are effective against RSV, leading to a 88% reduction in viral load.

SDSU researchers identify rare genetic markers of drug-resistant tuberculosis

Researchers at San Diego State University have identified rare genetic markers in M. tuberculosis that could improve early detection of drug-resistant strains of the disease, helping prevent their spread. These markers may help block common TB drugs from interfering with the pathogen's ability to synthesize proteins.

SourceSan Diego State University·JournalAntimicrobial Agents and Chemotherapy·TypeExperimental study·DateMay 9, 2022

Some cases of long COVID-19 may be caused by an abnormally suppressed immune system, UCLA-led research suggests

A UCLA-led team found that an abnormally suppressed immune system, not a persistently hyperactive one, may be to blame for some cases of long COVID-19. The study suggests boosting immunity in those individuals could be a treatment option.

SourceUniversity of California - Los Angeles Health Sciences·JournalClinical Infectious Diseases·TypeRandomized controlled/clinical trial·DateApr 22, 2022

New study shows increase in black lung disease in coal miners

A new study has found higher levels of silica dust in the lung tissue of contemporary coal miners compared to previous generations, providing a rationale for the Mine Safety and Health Administration to develop a more protective occupational standard for silica. The study suggests that changing mining practices, which generated more si...

SourceAmerican Thoracic Society·JournalAnnals of the American Thoracic Society·TypeSystematic review·DateApr 14, 2022

New Chinese Medical Journal study assesses mortality risk in multimorbid patients

A new study published in the Chinese Medical Journal assessed mortality risk in middle-aged and older Chinese individuals with multiple diseases. The study identified four multimorbidity patterns, with cardiometabolic being the most common, and found that individuals with these patterns had a significantly increased mortality risk.

SourceCactus Communications·JournalChinese Medical Journal·TypeObservational study·DateApr 13, 2022

Coughing mice and the fight against pertussis

A team of researchers from Osaka University successfully established a mouse model that can reproduce the severe and persistent cough of pertussis. They found that pertussis toxin, Vag8, and lipooligosaccharide are key bacterial factors involved in inducing coughing, which ultimately leads to bradykinin and TRPV1 signaling.

SourceOsaka University·JournalmBio·TypeExperimental study·DateMar 31, 2022

IgA antibodies seem to protect unvaccinated against COVID-19

A University of Gothenburg study found that IgA antibodies present in the respiratory tract protected healthcare workers from contracting COVID-19. The research, published in the European Journal of Immunology, suggests that these antibodies may play a crucial role in preventing severe illness and hospitalization.

SourceUniversity of Gothenburg·JournalEuropean Journal of Immunology·TypeObservational study·DateMar 24, 2022

Treating TB: uOttawa scientists collaborate to identify new drug for unique therapeutic approach

Researchers develop novel therapeutic approach for treating tuberculosis using phosphatase inhibitors, offering potential benefits for TB research and basic biology exploration. The discovery provides a promising alternative to traditional antibiotic-based treatments and has significant implications for combating antimicrobial resistance.

SourceUniversity of Ottawa·JournalCell Chemical Biology·TypeContent analysis·DateMar 22, 2022

Higher exposure to bisphenol a in the womb associated with increased risk for asthma and wheezing in school-age girls

A study of over 3,000 mother-child pairs from six European countries found an association between prenatal bisphenol A exposure and increased risk of asthma and wheezing in school-age girls. The study revealed a high prevalence of BPA in maternal urine during pregnancy.

SourceBarcelona Institute for Global Health (ISGlobal)·JournalEnvironment International·TypeObservational study·DateMar 18, 2022

Treatment length reduced for children with tuberculosis

Researchers found that four-month treatment is as effective as six months in non-severe TB cases, allowing for savings on screening and training healthcare workers. The study's results led to a change in the World Health Organisation's global guidelines, recommending a shorter treatment course for children with non-severe TB.

SourceUniversity College London·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateMar 9, 2022